SCHEMBL13479595

SCHEMBL13479595

O=c1nc(C(F)(F)F)cc(/C=C/c2ccc(-c3ccc(Br)cc3)o2)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.53
▸ KMT2A Q03164 8/20 0.53
▸ POLB P06746 6/20 0.53
▸ MAPT P10636 5/20 0.53
▸ HPGD P15428 3/20 0.53
▸ LMNA P02545 1/20 0.53
▸ PSD A5PKW4 1/20 0.47
▸ ALDH1A1 P00352 8/20 0.40
▸ KDM4E B2RXH2 7/20 0.40
▸ USP2 O75604 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ TLR9 Q9NR96 1/20 0.40
▸ BRAF P15056 1/20 0.40
▸ IGF1R P08069 1/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MAPK1 P28482 2/20 0.38
▸ HSP90AA1 P07900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662372 0.84 MEN1 (0.49) MEN1KMT2APOLBMAPTHPGD
SCHEMBL6664624 0.83 PSD (0.52) MEN1KMT2APOLBMAPTHPGD
SCHEMBL6663749 0.83 MAPT (0.48) MEN1KMT2APOLBMAPTHPGD
SCHEMBL6591623 0.83 KDM4E (0.55) MEN1KMT2APOLBMAPTHPGD
SCHEMBL6668285 0.83 MEN1 (0.52) MEN1KMT2APOLBMAPTHPGD
SCHEMBL6591626 0.83 KDM4E (0.55) MEN1KMT2APOLBMAPTHPGD
SCHEMBL16211020 0.82 PSD (0.55) MEN1KMT2APOLBMAPTHPGD
SCHEMBL16211019 0.82 PSD (0.55) MEN1KMT2APOLBMAPTHPGD
SCHEMBL6593887 0.80 MEN1 (0.82) MEN1KMT2APOLBMAPTHPGD
SCHEMBL6593893 0.80 MEN1 (0.82) MEN1KMT2APOLBMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659277-B2 Ubiquitin ligase inhibitors and methods related thereto Proteologies, Ltd. (IL) 2010-02-09 — — US disclosed
US-7659277-B2 Ubiquitin ligase inhibitors and methods related thereto Proteologies, Ltd. (IL) 2010-02-09 — — US disclosed
US-20070015768-A1 Ubiquitin ligase inhibitors and methods related thereto PROTEOLOGICS, LTD. (IL) 2007-01-18 — — US disclosed
US-20070015768-A1 Ubiquitin ligase inhibitors and methods related thereto PROTEOLOGICS, LTD. (IL) 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015768-A1 Ubiquitin ligase inhibitors and methods related thereto XIAP, NEDD4, MDM2 MEN1 3989/4885KMT2A 604/4885POLB 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback